Rocky Mountain Spotted Fever: Clinical Symptoms
Rocky Mountain spotted fever presents initially with nonspecific symptoms of fever, headache, and malaise, with the characteristic rash appearing 2-4 days after fever onset in most patients—but critically, less than 50% have a rash in the first 3 days and up to 20% never develop a rash at all. 1
Early Symptoms (First 3 Days)
The initial presentation is typically nonspecific and includes:
- Fever (sudden onset, present in nearly all cases) 1, 2
- Headache (severe, one of the most common early symptoms) 1, 2
- Malaise and fatigue 1, 2
- Myalgias (muscle pain throughout the body) 1, 2
- Chills 1, 2
- Nausea and vomiting 1
- Abdominal pain (can mimic appendicitis, cholecystitis, or gastroenteritis) 1, 2
- Anorexia 1, 2
- Photophobia 1, 2
Rash Characteristics and Timing
The classic triad of fever, rash, and tick bite is present in only a minority of patients at initial presentation, so clinicians must not wait for this triad before initiating treatment. 1, 3
Rash Evolution:
- Initial appearance: Small (1-5 mm diameter) blanching pink macules on ankles, wrists, or forearms, typically appearing 2-4 days after fever onset 1, 2
- Progression: Spreads to palms, soles, arms, legs, and trunk over subsequent days, usually sparing the face 1
- Advanced stage: Becomes maculopapular with central petechiae 1
- Classic petechial rash: Appears by day 5-6, involving palms and soles, indicating advanced disease 1, 2
Critical Rash Pitfalls:
- Less than 50% of patients have rash in first 3 days of illness 1, 3
- Up to 20% of patients never develop a rash 3, 4
- Rash may be atypical, localized, faint, or difficult to recognize in darker-skinned individuals 1
- Children under 15 years develop rash more frequently and earlier than adults 1
- Absence or late-onset rash is associated with diagnostic delays and increased mortality 1
Additional Clinical Features
- Conjunctival suffusion 1
- Periorbital and peripheral edema (more common in children) 1
- Calf pain 1
- Hepatomegaly and splenomegaly 1
- Diarrhea 1, 2
Severe Late-Stage Manifestations (Untreated Disease)
If treatment is delayed beyond day 5-6, severe complications develop:
- Meningoencephalitis 1, 2
- Acute renal failure 1, 2
- Acute respiratory distress syndrome (ARDS) 1, 2
- Cutaneous necrosis and gangrene (particularly digits) 1, 2
- Shock 1, 2
- Cardiac arrhythmias 2
- Seizures 2
- Disseminated intravascular coagulation (DIC) (rare) 1
Laboratory Findings
Common laboratory abnormalities include:
- Thrombocytopenia 1
- Hyponatremia 1, 4
- Elevated hepatic transaminases (slight increase) 1
- Normal or slightly increased white blood cell count with increased immature neutrophils 1
- Elevated creatine kinase or lactate dehydrogenase (later in course) 1
Timing and Mortality Risk
- Incubation period: 3-12 days after tick bite 1, 2
- Shorter incubation (≤5 days) associated with more severe disease 2
- Case-fatality rate: 5-10% overall 1, 4
- 50% of deaths occur within 9 days of illness onset 3
- Mortality increases dramatically with treatment delay: Patients treated after day 5 have significantly higher mortality, with 33-50% mortality by days 6-9 if treatment is delayed 1
Critical Clinical Pearls
Only approximately 60% of patients recall tick exposure, so absence of tick bite history should not exclude the diagnosis. 3, 5 The disease occurs most commonly April through September in wooded, shrubby, or grassy areas. 5, 6 Delay in recognition and treatment is the single most important factor associated with death from RMSF. 1, 2